戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 after diagnosis and treatment of a pediatric embryonal tumor.
2 y have utility for this and other MYC-driven embryonal tumors.
3 en younger than 3 years with newly diagnosed embryonal tumors.
4 r abnormalities, including increased risk of embryonal tumors.
5  kidney, consistent with a potential role in embryonal tumors.
6 sing functions that are disrupted in BWS and embryonal tumors.
7  the maternal allele in fetal brain and some embryonal tumors.
8 ulloblastoma/primitive neuroectodermal tumor/embryonal tumor, 17 had malignant astrocytoma, nine had
9 Younger patients with group 1 paratesticular embryonal tumors and all patients with group 1/2 orbit o
10  or of unknown cause, is not associated with embryonal tumors and cells from these individuals show m
11 RIP13 or BUB1B mutations have a high risk of embryonal tumors, and here we show that their cells disp
12                  Pediatric patients with CNS embryonal tumors are at high risk for treatment-related
13                              Wilms tumor, an embryonal tumor associated with disrupted organogenesis,
14                       Overall, patients with embryonal tumors benefited from intensive three-drug che
15 c tumors representing sarcomas, extracranial embryonal tumors, brain tumors, hematologic malignancies
16 ally invasive or metastatic tumors, in which embryonal tumor cells are EGFR-negative, while SCU cells
17 stnatal tissue overgrowth, increased risk of embryonal tumors during early childhood, and numerous vi
18   Conversely, at an older age, mice escaping embryonal tumor formation present with malignant gliomas
19                  Genomic analysis shows that embryonal tumors have more structural and copy number va
20 region implicated in the etiology of several embryonal tumors, including Wilms tumor, and in Beckwith
21 et consistent with a time-limited window for embryonal tumor initiation.
22 unger than 3 years with primary intracranial embryonal tumors is now in progress.
23 ne abdominal wall defects, macroglossia, and embryonal tumors, is a model for understanding the relat
24 toma and neuroblastoma exemplify the current embryonal tumor model.
25 ts in this group are highly prone to develop embryonal tumors, most commonly medulloblastoma arising
26 ryoid tumors (n = 19), 26% for patients with embryonal tumors (n = 313), and 5% for patients with alv
27 are highly aggressive, poorly differentiated embryonal tumors occurring predominantly in young childr
28  human tumors including rhabdomyosarcoma, an embryonal tumor of skeletal muscle origin.
29  and ErbB-4 in childhood medulloblastoma, an embryonal tumor of the cerebellar external granule cell
30           Medulloblastoma is a heterogeneous embryonal tumor of the cerebellum comprised of four dist
31 lopment and the medulloblastoma, a malignant embryonal tumor of the cerebellum, have proven especiall
32 f children with medulloblastoma, a malignant embryonal tumor of the cerebellum, succumb to their dise
33 oter hypermethylation in medulloblastoma, an embryonal tumor of the cerebellum.
34            Neuroblastoma (NB) is a malignant embryonal tumor of the sympathetic nervous system that i
35 selective radioimmunoconjugates specific for embryonal tumors of childhood are currently being active
36                                              Embryonal tumors of the CNS include, among others, medul
37      Analysis of the subset of patients with embryonal tumors showed similar results (P =.0008).
38 bear a genetic similarity to other infantile embryonal tumors such as hepatoblastomas.
39 rnally expressed imprinted genes involved in embryonal tumor suppression and the cancer-predisposing
40  subtransferable fragment (STF) harboring an embryonal tumor-suppressor gene and spanning about 2.5 M
41  rhabdomyosarcoma and are more effective for embryonal tumors than therapies used previously.
42                            For patients with embryonal tumors, the estimated 5-year survival rate was
43                        Medulloblastoma is an embryonal tumor thought to arise from the granule cell p
44 e at the clinical presentation of peripheral embryonal tumors was 1.0, at the onset of hematologic ma
45                     Hepatoblastoma is a rare embryonal tumor with unknown etiology.
46                                              Embryonal tumors with multilayered rosettes (ETMRs) are
47                                              Embryonal tumors with multilayered rosettes (ETMRs) are
48 lip-derived mossy fiber neuronal lineage and embryonal tumors with multilayered rosettes fully recapi
49          Intraocular medulloepitheliomas and embryonal tumors with multilayered rosettes of the brain